Product Information
RIVAROXABAN 2.5 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.7967 per EA under NDC 51672422809. Its NADAC has been published 24 times since Jan 14, 2026.
Strength
2.5 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672422809
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RIVAROXABANApproval Type
Generic (ANDA)
FDA Application
ANDA208557On Market Since
10/15/2025
Pharmacological Classes
Price Statistics
The NADAC for RIVAROXABAN 2.5 MG TABLET has been published 24 times since Jan 14, 2026, and over the history we have for it it has declined 43.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7967 per EA |
|---|---|
| All-time high | $1.4044 (Jan 14, 2026) |
| All-time low | $0.7967 (Jun 17, 2026) |
| 52-week high | $1.4044 |
| 52-week low | $0.7967 |
| Median price | $0.9790 |
| Average price | $1.0011 |
| Largest weekly change | -19.6% (Jan 21, 2026) |
| Weeks tracked | 24 |
| Tracking since | Jan 14, 2026 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RIVAROXABAN 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RIVAROXABAN 2.5 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.7967 per EA (NDC 51672422809), effective Jun 24, 2026.
How has the price of RIVAROXABAN 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for RIVAROXABAN 2.5 MG TABLET has declined 43.3%. It has been tracked across 24 weekly CMS publications since Jan 14, 2026.
What are the highest and lowest recorded NADAC prices for RIVAROXABAN 2.5 MG TABLET?
Since Jan 14, 2026, the NADAC for RIVAROXABAN 2.5 MG TABLET has ranged from a low of $0.7967 (Jun 17, 2026) to a high of $1.4044 (Jan 14, 2026), with a median of $0.9790 per EA.
Are there cheaper alternatives to RIVAROXABAN 2.5 MG TABLET?
7 NADAC-published products share the same active ingredient, strength, and dosage form as RIVAROXABAN 2.5 MG TABLET, but none are currently priced below it.
Who manufactures RIVAROXABAN 2.5 MG TABLET?
RIVAROXABAN 2.5 MG TABLET (NDC 51672422809) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification